12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Gainers included Nymox Pharmaceutical (NASDAQ:NYMX), Ensysce Biosciences (NASDAQ:ENSC), IMAC Hldgs (NASDAQ:BACK), Journey Medical (NASDAQ:DERM), Ventyx Biosciences (NASDAQ:VTYX), and Nemaura Medical (NASDAQ:NMRD). Losers included Protagonist Therapeutics (NASDAQ:PTGX), Xtant Medical Hldgs (AMEX:XTNT), Baudax Bio (NASDAQ:BXRX), Icosavax (NASDAQ:ICVX), Omega Therapeutics (NASDAQ:OMGA), and Laboratory Corp (NYSE:LH).

July 04, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Protagonist Therapeutics's stock decreased by 19.7% to $22.18 during Tuesday's regular session.
The significant decrease in Protagonist Therapeutics's stock price is likely due to negative market sentiment towards the company. This could potentially lead to further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Xtant Medical Hldgs's stock declined by 16.32% to $0.78.
The significant decrease in Xtant Medical Hldgs's stock price is likely due to negative market sentiment towards the company. This could potentially lead to further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Ensysce Biosciences's shares rose 31.11% to $2.36.
The significant increase in Ensysce Biosciences's stock price is likely due to positive market sentiment towards the company. This could potentially lead to further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Nymox Pharmaceutical's stock moved upwards by 31.7% to $0.25 during Tuesday's regular session.
The significant increase in Nymox Pharmaceutical's stock price is likely due to positive market sentiment towards the company. This could potentially lead to further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100